GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹349 Cr | ₹256 Cr | ₹230 Cr | ₹132 Cr | ₹68 Cr |
What is the latest Total Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹349 Cr |
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹132 Cr |
| Mar2022 | ₹68 Cr |
How is Total Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹349 Cr | 36.28 | |
| Mar2025 | ₹256 Cr | 11.36 | |
| Mar2024 | ₹230 Cr | 73.82 | |
| Mar2023 | ₹132 Cr | 94.30 | |
| Mar2022 | ₹68 Cr | - | |
Compare Total Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹227.8 Cr | 4.7% | -5.3% | -47.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 4.7% |
-5.3% |
-47.1% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses